SLC22A9 Knockout Huh-7 Cell Line
Cat.No.:
EDC08329
Species:
Human
Cell Name:
Huh-7
Gene:
SLC22A9
Gene ID:
114571
Size:
1×10⁶cells
SLC22A9 Knockout Huh-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08329 |
|---|---|
| Product Name | SLC22A9 Knockout Huh-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene ID | |
| Gene | SLC22A9 |
| Summary |
Enables short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Located in basolateral plasma membrane. Implicated in Lynch syndrome and mismatch repair cancer syndrome. [provided by Alliance of Genome Resources, Jul 2025]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 70% Complete medium + 20% FBS + 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC22A9 function, SLC22A9 Knockout Huh-7 Cell Line or SLC22A9 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC22A9 (OAT7)'s role as a hepatocyte-specific organic anion transporter or its emerging functions in bile acid sulfate and drug uptake. The Knockout line is the standard tool for asking whether OAT7 is required for cellular uptake of its substrates — OAT7 is principally expressed in liver and transports sulfated steroids, bile acid sulfates, and butyrate. Overexpression is useful for substrate scope characterization and drug-substrate interaction studies.
For OAT family research, the EDITGENE OAT7 Knockout in Huh-7 is particularly relevant — Huh-7 is a hepatocellular line and OAT7 is liver-specific within the OAT family. Rescue with wild-type or transport-deficient OAT7 enables structure-function studies. The knockout serves as a specificity control for organic anion drug interaction studies in hepatic contexts.
What are the application scenarios for this model?
Primary applications:
• Sulfated steroid uptake: estrone-3-sulfate, DHEA-S, and other sulfated steroid transport assays.
• Bile acid sulfate transport: assessment of OAT7's role in hepatic bile acid sulfate handling.
• Butyrate transport: short-chain fatty acid uptake studies given OAT7's reported butyrate handling.
• Drug-transporter interactions: assessment of clinical drug substrates that interact with hepatic OAT7.
EDITGENE recommends this model for researchers investigating hepatic organic anion transport, bile acid biology, and OAT family pharmacology.
Is this SLC22A9 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes. OAT7 rescue experiments require attention to hepatocyte-specific function:
• Construct design: use a codon-modified SLC22A9 sequence with a small C-terminal tag (FLAG, HA). OAT7 has 12 transmembrane domains in the canonical SLC22 architecture.
• Surface localization validation: confirm plasma membrane localization before transport assays.
• Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies.
• Functional readout: rescue should restore sulfated steroid and bile acid sulfate uptake activities.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatic context.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.